Hackers have exposed heavily redacted information from the latest 11,034 documents in the Epstein files, released on Monday.

A threat actor known as Zestix has been offering to corporate data stolen from dozens of companies likely after breaching ...

Popular AI-powered integrated development environment solutions, such as Cursor, Windsurf, Google Antigravity, and Trae, ...

Here’s every working Terra Invicta console command, what they do, and how to enable the debug console in the full release.

All your files, apps, and settings are on your old computer. Here’s how to move them to your new Windows PC, from either Windows or macOS. It’s great to get a new computer, but it’s not so great to ...

A certified check is a safe payment option available at banks and credit unions. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take ...

Major retailers, or the payer’s bank or credit union, can cash a check for a small fee. But the better option is your own financial institution. Many, or all, of the products featured on this page are ...

Osi Momoh is an expert on corporate finance and accounting, bonds, trading, cryptocurrency, and much more. Osi has 10+ years of experience in the investment industry, having served as a client-facing ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...

In mid-December 2025, an image (archived) circulated online purportedly showing U.S. President Donald Trump using a walker as a mobility aid. Keith Edwards, a Democratic political strategist, posted ...

With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trials This approval ...

With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trials NEW YORK, Dec.